Peptides are the last five percent — the first ninety-five are training, food and sleep.
This is not a moral argument about doing things the hard way. It is an effect-size argument. The measured benefits of being fit, strong and adequately fed are large, repeatedly replicated, and available to everyone. Peptides act at the margin of that. If the foundation is missing, the margin is where you are spending money for very little return.
- In a cohort of 122,007 adults, the mortality risk of low cardiorespiratory fitness was comparable to or greater than that of smoking, diabetes and coronary artery disease.
- Resistance training shows a mortality benefit at surprisingly small doses — the meta-analytic peak sits around 60 minutes a week, and a 30-year cohort found no additional benefit above roughly 120 minutes a week.
- Gains in fat-free mass plateau at about 1.6 g of protein per kg of body weight per day. Above that, more protein did not produce more muscle in the pooled data.
- Protein supplementation without resistance training does not increase muscle strength. The training is the stimulus; the food is permission.
- “Superfood” has no regulatory definition, and in the EU it cannot be used to market a product unless it is paired with an authorised health claim.
The one number that predicts the most
If you only measured one thing, measure aerobic fitness. A Cleveland Clinic cohort followed 122,007 adults who had undergone treadmill testing, with a median follow-up of 8.4 years. Risk-adjusted all-cause mortality fell continuously as fitness rose: elite performers had roughly a fifth of the mortality risk of the lowest-fitness group.
Two details in that paper matter more than the headline. First, there was no observed upper limit of benefit — the curve did not flatten out at “fit enough”. Second, the excess mortality associated with low fitness was comparable to or greater than that associated with coronary artery disease, diabetes and smoking. Low fitness is not a soft lifestyle variable sitting below the real risk factors. In that dataset it sat alongside them.
No peptide in the research literature has an effect size in that neighbourhood, and none is close to being tested at that scale.
Strength training: the effective dose is smaller than you think
The common assumption is that meaningful strength work means many hours a week. The mortality data says otherwise. A 2022 systematic review and meta-analysis of ten cohort studies found that any amount of resistance training was associated with a 15% lower risk of all-cause mortality, 19% lower cardiovascular mortality and 14% lower cancer mortality, compared with none. In the dose-response analysis, the maximum reduction — about 27% — landed at around 60 minutes per week, and the benefit diminished at higher volumes.
A more recent analysis using repeated measurements across three large cohorts (147,374 participants, up to 30 years of follow-up) found the same shape at a slightly higher dose: 90 to 119 minutes per week was associated with 13% lower all-cause and 19% lower cardiovascular mortality, with no additional benefit above roughly 120 minutes per week.
The same analysis found the lowest risk of all in people who did both: high aerobic activity combined with resistance training. That combination, not either one alone, is the actual target.
Protein: the number that stops moving
The most cited meta-analysis on this question pooled 49 studies and 1,863 participants. Protein supplementation did produce real additional gains in strength and fat-free mass on top of resistance training — and the dose-response curve flattened at about 1.62 g/kg/day. Above that breakpoint, more protein did not produce more fat-free mass in the pooled data. The confidence interval around that estimate runs from roughly 1.0 to 2.2 g/kg/day, which is where the familiar 1.6–2.2 range comes from.
Two secondary findings are more interesting than the headline number. The effect of supplementation was blunted by increasing age and amplified by training experience — so the people who benefit most from getting protein right are the ones already training seriously. And in a separate dose-response meta-analysis, muscle strength could not be increased by protein supplementation without resistance training at all.
That is the whole hierarchy in one sentence. Training is the stimulus. Protein is permission for the adaptation to happen. Neither substitutes for the other, and no compound substitutes for either.
Supplements: a very short list survives scrutiny
Most of the supplement aisle does not hold up. Creatine monohydrate is the clearest exception. The International Society of Sports Nutrition’s position stand describes it as the most effective ergogenic nutritional supplement currently available for increasing high-intensity exercise capacity and lean body mass during training, and concludes that it is well tolerated and safe in healthy trained and untrained individuals regardless of age, with no compelling evidence of harm in long-term use.
That is an unusually strong statement in a field where most supplements are supported by a handful of small trials. It is also worth noting what the position stand does not say: creatine does not replace training, and it does not work in the absence of a training stimulus.
Everything else — vitamin D, omega-3, magnesium and the rest — is best treated as correcting a deficiency you have actually measured, not as a performance lever. Test first, then supplement the gap. That is the same logic this site applies to peptides.
A word about “superfoods”
It is worth being precise here, because the term does real work in marketing. “Superfood” has no official definition from any major regulator, including EFSA and the FDA. In the European Union it has been treated since 2007 as a general health claim under the nutrition and health claims regulation, which means a product cannot be marketed as a superfood unless the claim is accompanied by a specific authorised health claim backed by evidence.
That is not a reason to avoid blueberries. It is a reason to stop treating any individual food as a lever. The dietary pattern does the work: enough total protein, enough energy to support training, enough fibre and micronutrients from a varied diet. No single ingredient in that pattern is doing something the others cannot.
So where do peptides actually fit?
At the margin, and only once the margin is the thing limiting you. A peptide with genuine published pharmacokinetics, used by someone who trains consistently, eats enough protein and sleeps properly, is operating on a system that is already adapting. The same compound used to compensate for inconsistent training and a guessed diet is being asked to do something nothing in the literature says it can do.
There is also a practical argument. If you change four things at once — training, diet, sleep and a compound — you learn nothing about any of them. Getting the foundations stable first is what makes it possible to tell whether a compound did anything at all.
The honest summary: the interventions with the largest, best-replicated effects are unglamorous, free, and available today. Peptides are a real field with real pharmacology, and they belong at the end of that list rather than the start of it.
PeptideCompare exists to make peptide pricing and quality transparent, not to expand the number of people using peptides. If the foundations described here are not in place, the most accurate advice we can give is that a compound purchase is unlikely to be the thing that changes your outcome.
Sources
- Mandsager K, et al. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing. JAMA Network Open, 2018;1(6):e183605. pmc.ncbi.nlm.nih.gov
- Shailendra P, et al. Resistance Training and Mortality Risk: A Systematic Review and Meta-Analysis. American Journal of Preventive Medicine, 2022. www.sciencedirect.com
- Long-term resistance training with all-cause and cause-specific mortality: dose-response and joint associations with aerobic physical activity. British Journal of Sports Medicine (PMID 42230125). pubmed.ncbi.nlm.nih.gov
- Morton RW, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. British Journal of Sports Medicine, 2018. www.ncbi.nlm.nih.gov
- Kreider RB, et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. J Int Soc Sports Nutr, 2017;14:18. pmc.ncbi.nlm.nih.gov
- Regulation (EC) No 1924/2006 on nutrition and health claims made on foods — the basis on which “superfood” is treated as a general health claim in the EU. marketinglaw.osborneclarke.com